Bill
Bill > HB1984
TN HB1984
TN HB1984AN ACT to amend Tennessee Code Annotated, Title 53, Chapter 11, relative to the use of buprenorphine products.
summary
Introduced
01/22/2026
01/22/2026
In Committee
02/18/2026
02/18/2026
Crossed Over
Passed
Dead
Introduced Session
114th General Assembly
Bill Summary
As introduced, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.
AI Summary
This bill expands the ability of certain healthcare providers to directly administer buprenorphine, a medication used to treat opioid use disorder, either as a standalone product (mono) or without naloxone, which is an opioid overdose reversal medication often combined with buprenorphine to deter misuse. Specifically, it clarifies that prescribing buprenorphine to a nursing mother or prescribing an injectable mono product does not prevent these healthcare providers from prescribing buprenorphine without naloxone for opioid use disorder treatment. The bill amends existing Tennessee law to allow for this broader administration and prescribing of buprenorphine products under specific circumstances.
Committee Categories
Health and Social Services
Sponsors (3)
Last Action
Placed on cal. Health Committee for 3/10/2026 (on 03/04/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://wapp.capitol.tn.gov/apps/Billinfo/default.aspx?BillNumber=HB1984&ga=114 |
| Fiscal Note - SB1848 | https://www.capitol.tn.gov/Bills/114/Fiscal/SB1848.pdf |
| BillText | https://www.capitol.tn.gov/Bills/114/Bill/HB1984.pdf |
Loading...